Clinical Trials Browser

Unknown × Interventional × Thoracic × Clear all

NCT04432207 2024-11-07

A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults with Non-Small Cell Lung Cancer

Phase 1 Unknown

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT05830097 2024-08-26

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT04922658 2024-07-31

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

Phase 2 Unknown

Advanced Non-Small Cell Lung Cancer

NCT06128694 2024-07-30

Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients

Phase 3 Unknown

GynecologicThoracic

Uterine Cervical Neoplasms, Kwashiorkor, Lung Neoplasms, Neoplasms, Malnutrition

NCT05183243 2024-07-16

GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results

Phase 1 Unknown

GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT03921671 2024-05-29

RELEVENT

Phase 2 Unknown

Neoplasm Metastasis, Thymoma

NCT06406673 2024-05-09

A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer

Phase 2 Unknown

Extensive Small Cell Lung Cancer

NCT06150131 2024-04-12

Exercise Intervention After Lung Cancer Surgery

Phase NA Unknown

Rehabilitation After Lung Cancer Surgery

NCT06356701 2024-04-10

Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC

Phase 1 Unknown

Lung Neoplasms

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Phase 2 Unknown

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT05143970 2024-03-20

CHANCES

Phase 1 Unknown

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT05649046 2024-03-18

PREVALUNG*

Phase NA Unknown

Lung Neoplasms, Bronchitis, Chronic, Plaque, Atherosclerotic

NCT06293833 2024-03-05

ZORALCS

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Smoking Cessation, Small Cell Lung Carcinoma

NCT03865511 2024-02-28

MELROSE

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06279754 2024-02-28

Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy

Phase 2 Unknown

Locally Advanced Squamous Non-small Cell Lung Cancer

NCT06281860 2024-02-28

PITHAC

Phase 1 Unknown

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT05957510 2024-02-22

Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT03924466 2024-02-16

VUBAR

Phase 2 Unknown

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06262555 2024-02-16

Novel Light Delivery Method for Performing Transbronchial Photodynamic Therapy for Peripheral Lung Cancer

Phase NA Unknown

Lung Neoplasms

NCT06258954 2024-02-14

Effect of 3D-printed Reconstruction System in Size of Left DLT

Phase NA Unknown

Lung Neoplasms

NCT05829057 2024-02-13

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

Phase 1 Unknown

GastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT03274479 2024-02-09

PBF-1129 in Patients With NSCLC

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05602259 2024-02-09

PROTEON

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT01871454 2024-02-07

Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers

Phase 2 Unknown

Non-small Cell Lung Cancers

NCT05739695 2024-02-06

A Trial of Radial EBUS Versus VBN for the Peripheral Pulmonary Lesions

Phase NA Unknown

Lung Neoplasms, Pneumonia, Tuberculosis

NCT05946460 2024-02-06

Neoadjuvant Aumolertinib in Patients With AI-diagnosed EGFR-mutant High-risk Pulmonary Ground-glass Opacity.

Phase 2 Unknown

Lung Neoplasms

NCT06239584 2024-02-02

Generation of Lung Tumor Organoids From Patients Undergoing Diagnostic Bronchoscopy

Phase NA Unknown

Generation of Lung Cancer Organoids

NCT05861947 2024-01-31

JIVAN

Phase 1 Unknown

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Colonic Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Recurrence, Stomach Neoplasms

NCT05647590 2024-01-30

SBRT/RT in Oligometastatic Stage IV NSCLC

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT05278975 2024-01-26

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Phase 1/2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Pleural Effusion, Malignant

NCT06101394 2024-01-25

RECOGNISE

Phase 2 Unknown

Lung Neoplasms

NCT06208033 2024-01-17

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

Phase EARLY_PHASE1 Unknown

EGFR Positive Non-small Cell Lung Cancer

NCT06207292 2024-01-16

STARTNEWERA-OM

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT05092412 2024-01-12

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

Phase 2 Unknown

Lung Neoplasms, Small Cell Lung Carcinoma

NCT05296603 2024-01-10

Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung Cancer

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT05248022 2024-01-09

Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT06187740 2024-01-09

Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapy

Phase 1 Unknown

Small Cell Lung Carcinoma

NCT04826835 2024-01-08

A Prehabilitation Program to Boost Postoperative Functional Capacity in Surgical Lung Cancer Patients

Phase NA Unknown

Lung Neoplasms, Motor Activity

NCT06194630 2024-01-08

Application of 68Ga-labeled ACE2 Targeting Probe PET/CT Imaging in Tracing ACE2 Expression and Diagnosis of Lung Cancer

Phase EARLY_PHASE1 Unknown

Lung Neoplasms

NCT06195683 2024-01-08

NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06152419 2024-01-05

Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project

Phase NA Unknown

BreastGastrointestinalGenitourinaryHead & NeckThoracic

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT03807102 2023-12-29

TVATLC01

Phase 1/2 Unknown

Lung Neoplasms

NCT04937972 2023-12-29

FLYFLY

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05611879 2023-12-29

Neoadjuvant of Tislelizumab Combined With Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02098954 2023-12-27

Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03646968 2023-12-27

SAVE

Phase 2 Unknown

Non-Squamous Non Small Cell Lung Cancer

NCT06182800 2023-12-27

Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03256981 2023-12-26

HALT

Phase 2/3 Unknown

NSCLC

NCT02950337 2023-12-21

Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT05730972 2023-12-13

TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer

Phase NA Unknown

Cancer Pain, Carcinoma, Non-Small-Cell Lung